A recent study conducted by the Mount Sinai Hospital System’s Department of Health Evidence and Policy and published by the British Medical Journal found that the use of tranexamic acid decreases the need for blood transfusions without increasing the risk for thromboembolic events or renal failure in patients undergoing either form of joint replacement surgery.

/by

A recent study conducted by the Mount Sinai Hospital System’s Department of Health Evidence and Policy and published by the British Medical Journal found that the use of tranexamic acid decreases the need for blood transfusions without increasing the risk for thromboembolic events or renal failure in patients undergoing either form of joint replacement surgery.